Boiron S.A. operates as a global pharmaceutical manufacturer with a primary focus on homeopathic treatments. The company's revenue is primarily driven by its non-proprietary homeopathic medicines and branded over-the-counter specialties, such as Oscillococcinum for flu symptoms, the Arnicare line for pain relief, and Camilia for teething. In addition to its core homeopathic portfolio, Boiron manufactures dietary supplements, herbal medicines, cosmetics, and medical devices. Headquartered in Messimy, France, the company distributes its products across more than 50 countries in Europe, North America, and other international markets. The firm reaches consumers through a distribution network that includes pharmacies, wholesalers, health food stores, and direct-to-consumer online platforms.
